← Back to all trials
Not Yet Recruiting
NCT07636161
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
Conditions: Type 2 Diabetes, Type 2 Diabetes (T2DM)
Sex: Male
Ages: 18 Years – 40 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 30
Sponsor: University of Miami
Location: Don Soffer Clinical Research Building Miami Florida
Summary
The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.
Eligibility Criteria
Inclusion Criteria:
* Male sex at birth
* Age 18-40 years
* Diagnosis of type 2 diabetes mellitus
* Diagnosis of erectile dysfunction
* Currently prescribed tadalafil
* Have a sexual partner willing to complete a survey
* Ability to provide informed consent
Exclusion Criteria:
* Type 1 diabetes mellitus
* Severe psychiatric illness that would impair participation
* Use of nitrates or contraindications to sexual activity
* Known allergy to Eroxon® gel components
* Participation in another interventional sexual health study
Source: ClinicalTrials.gov (NCT07636161). StuddyBuddy aggregates publicly available trial information.
